FATE CIK: 1434316

Fate Therapeutics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−163
FY22:
−248
FY23:
−132
FY24:
−123
FY25:
−106
Change from FY21 to FY25
millions USD
FY21:
−324
FY22:
167
FY23:
113
FY24:
12.2
FY25:
111
Change from FY21 to FY25
millions USD
FY21:
453
FY22:
9.21
FY23:
0.09
FY24:
99.9
FY25:
5.49
millions USD
FY21:
−33.8
FY22:
−72.3
FY23:
−19.5
FY24:
−10.8
FY25:
10.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−214
FY22:
−284
FY23:
−138
FY24:
−124
FY25:
−112

All amounts in millions USD Data source:SEC EDGAR